课题基金 / 基金详情

Designer cells controlled by synthetic genomes.

Designer cells controlled by synthetic genomes.
由合成基因组控制的设计细胞。
批准号:
RGPIN-2018-06172
负责人:
Karas, Bogumil
金额:
$3.42万
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-01-01 至 2020-12-31

项目摘要

项目成果

Karas, Bogumil的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Research in my laboratory uses Synthetic Biology to solve some of the most pressing challenges of our times, such as increased demand for food, clean water, fuel, and crucial medicines. To achieve these goals, I am developing molecular tools for generating designer organisms that are programmed by synthetic genomes. DNA synthesis technology is predicted to become much more powerful and affordable in the near future, thanks to a new global collaborative effort named Genome Project write (GP-write). GP-write aims to invest up to $3 billion USD over the next ten years to reduce the cost of creating synthetic DNA. To take advantage of this rapidly advancing DNA synthesis technology, improved methods for moving and storing large synthetic DNA fragments need to be developed. Thus, I propose an efficient method for construction and installation of synthetic genomes into a cell's organelles, such as mitochondriathe cell's “power plant”and chloroplaststhe cell's light-harvesting factory used in photosynthesis. This research program will enable the production of organisms and technologies with greater value for Canadians: crop plants with new biological functions, such as nitrogen fixation, to reduce the need for fertilizers; algal strains with higher lipid content to provide a cheap source of biofuels; and medical treatments for diseases associated with damaged mitochondrial genomes, such as some cases of diabetes, deafness, and Parkinson's. Moreover, this project will provide cutting-edge Synthetic Biology training for a new generation of scientists in techniques such as molecular DNA cloning, DNA synthesis, and whole-genome transplantation. At the end of their training, my trainees will have the knowledge and experience to implement their own ideas for designer organisms, which will help furnish the development of new patented technologies and new biotech companies in Canada.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Designer cells controlled by synthetic genomes.
  • 批准号:
    RGPIN-2018-06172
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.42万
  • 财政年份:
    2022
  • 负责人:
    Karas, Bogumil
  • 依托单位:
Designer cells controlled by synthetic genomes.
  • 批准号:
    RGPIN-2018-06172
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.42万
  • 财政年份:
    2021
  • 负责人:
    Karas, Bogumil
  • 依托单位:
Designer cells controlled by synthetic genomes.
  • 批准号:
    RGPIN-2018-06172
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.42万
  • 财政年份:
    2020
  • 负责人:
    Karas, Bogumil
  • 依托单位:
A fluorescent microscopy suite for visualization of synthetic organelles and cells.
  • 批准号:
    RTI-2020-00698
  • 项目类别:
    Research Tools and Instruments
  • 资助金额:
    $10.91万
  • 财政年份:
    2019
  • 负责人:
    Karas, Bogumil
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位:
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
  • 批准号:
    82371801
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    周海波
  • 依托单位:
脐带间充质干细胞微囊联合低能量冲击波治疗神经损伤性ED的机制研究
  • 批准号:
    82371631
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    卢慕峻
  • 依托单位: